A review of combination adjuvants for malaria vaccines: a promising approach for vaccine development
Authors:
- 1 August 2021
- journal article
- review article
- Published by Elsevier in International Journal for Parasitology
- Vol. 51 (9) , 699-717
Abstract
No abstract availableKeywords
This publication has 215 references indexed in Scilit:
- A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African InfantsNew England Journal of Medicine, 2012
- Alum increases antigen uptake, reduces antigen degradation and sustains antigen presentation by DCs in vitroImmunology Letters, 2012
- Design considerations for liposomal vaccines: Influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigensVaccine, 2012
- First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African ChildrenNew England Journal of Medicine, 2011
- Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trialThe Lancet Infectious Diseases, 2011
- Protection of mice from Mycobacterium tuberculosis by ID87/GLA-SE, a novel tuberculosis subunit vaccine candidateVaccine, 2011
- A Field Trial to Assess a Blood-Stage Malaria VaccineNew England Journal of Medicine, 2011
- Programming the magnitude and persistence of antibody responses with innate immunityNature, 2011
- Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of AgeNew England Journal of Medicine, 2008
- The Nlrp3 inflammasome is critical for aluminium hydroxide‐mediated IL‐1β secretion but dispensable for adjuvant activityEuropean Journal of Immunology, 2008